ASCs are increasingly at the forefront of colorectal cancer prevention efforts, particularly as new screening technologies gain traction. Following recent FDA approvals, ASCs are stepping up to ...

A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns. Pharmacy-based colorectal cancer (CRC) ...

Multitarget stool DNA tests — which are becoming more popular in the United States — have shown increased sensitivity over fecal immunochemical tests (FITs) for early colorectal cancer (CRC) screening ...

Mailed fecal immunochemical testing completion rates among adults overdue for colorectal cancer screening improved after ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Younger vs. older patients achieved a higher rate of ...

Among nearly 25 million privately insured adults, significant shifts in colorectal cancer (CRC) screening practices were identified after the onset of COVID-19. 1 Between 2017 and 2024, colonoscopy ...

Cancer is a life threatening condition, and its early diagnosis and prevention are the only two things that matter before it ...